Literature DB >> 3258501

Role of Langerhans cells in epidermotropism of T cells.

T Shiohara1, N Moriya, K M Saizawa, M Nagashima.   

Abstract

Certain T lymphocytes display a specific affinity for the epidermis (epidermotropism). Recent studies have suggested that Ia+ Langerhans cells (LCs) are possible targets for the epidermotropism. A variety of self-Ia-reactive cloned T cells were tested for their ability to migrate into the epidermis following intradermal inoculation into the footpads of syngeneic mice. Clone BB5 was chosen as representative of the epidermotropic T cells. We investigated whether the depletion of Ia+ LCs from the epidermis by tape-stripping could alter the migration of BB5 cells into the epidermis. The epidermal invasion of BB5 cells was markedly impaired in those mice whose LCs were depleted by 95% after repetitive tape-stripping. Because production of epidermal-derived thymocyte activating factor (ETAF) by the epidermal cells was augmented after repetitive tape-stripping, the diminished migration of BB5 cells into tape-stripped epidermis did not result from a decrease in ETAF production which is thought to attract T cells chemotactically. These results suggest that Ia+ LCs may play an inductive role in the preferential migration of T cells into the epidermis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3258501     DOI: 10.1007/bf00412686

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  24 in total

1.  Epidermal cell-derived thymocyte activating factor (ETAF) is a potent T-cell chemoattractant.

Authors:  D N Sauder; M M Monick; G W Hunninghake
Journal:  J Invest Dermatol       Date:  1985-11       Impact factor: 8.551

2.  Presence of epidermal-derived thymocyte activating factor/interleukin 1 in normal human stratum corneum.

Authors:  L C Gahring; A Buckley; R A Daynes
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

3.  Immunologic aspects of acute cutaneous graft-versus-host disease: decreased density and antigen-presenting function of Ia+ Langerhans cells and absent antigen-presenting capacity of Ia+ keratinocytes.

Authors:  S M Breathnach; S Shimada; Z Kovac; S I Katz
Journal:  J Invest Dermatol       Date:  1986-03       Impact factor: 8.551

4.  Anti-tumor activity of class II MHC antigen-restricted cloned autoreactive T cells. I. Destruction of B16 melanoma cells mediated by bystander cytolysis in vitro.

Authors:  T Shiohara; N H Ruddle; M Horowitz; G E Moellmann; A B Lerner
Journal:  J Immunol       Date:  1987-03-15       Impact factor: 5.422

5.  Keratinocyte-derived T-cell growth factor: a T-cell growth factor functionally distinct from interleukin 2.

Authors:  T S Kupper; D L Coleman; J McGuire; D Goldminz; M C Horowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

6.  Lichen planus and chronic graft-versus-host reaction. In situ identification of immunocompetent cell phenotypes.

Authors:  M A Gomes; D S Schmitt; P Souteyrand; C Ohrt; J Brochier; J Thivolet
Journal:  J Cutan Pathol       Date:  1982-08       Impact factor: 1.587

7.  Mechanism of systemic immune suppression by UV irradiation in vivo. II. The UV effects on number and morphology of epidermal Langerhans cells and the UV-induced suppression of contact hypersensitivity have different wavelength dependencies.

Authors:  F P Noonan; C Bucana; D N Sauder; E C De Fabo
Journal:  J Immunol       Date:  1984-05       Impact factor: 5.422

8.  Natural and perturbed distributions of Langerhans cells: responses to ultraviolet light, heterotopic skin grafting, and dinitrofluorobenzene sensitization.

Authors:  P R Bergstresser; G B Toews; J W Streilein
Journal:  J Invest Dermatol       Date:  1980-07       Impact factor: 8.551

9.  Langerhans cells are not damaged in contact allergic reactions in humans.

Authors:  B Giannotti; G De Panfilis; G C Manara; P Cappugi; C Ferrari
Journal:  Am J Dermatopathol       Date:  1986-06       Impact factor: 1.533

10.  Effect of glucocorticosteroids on epidermal Langerhans cells.

Authors:  D V Belsito; T J Flotte; H W Lim; R L Baer; G J Thorbecke; I Gigli
Journal:  J Exp Med       Date:  1982-01-01       Impact factor: 14.307

View more
  2 in total

1.  Langerhans' cells are depleted in chronic graft versus host disease.

Authors:  S Aractingi; E Gluckman; M C Dauge-Geffroy; C Le Goué; A Flahaut; L Dubertret; E Carosella
Journal:  J Clin Pathol       Date:  1997-04       Impact factor: 3.411

2.  Langerhans cells in human middle ear cholesteatomas.

Authors:  W Y Chao; Y T Jin; C C Huang
Journal:  Eur Arch Otorhinolaryngol       Date:  1992       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.